Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Afatinib in NSCLC With HER2 Mutation [Phase 2]
Phase 2 trial update of afatinib in non-small cell lung cancer with HER2 mutation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers [Phase 3]
Phase 3 trial evaluating early palliative care added to standard care versus standard care alone in patients with incurable lung or non-colo…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation [Phase 3]
Phase 3 trial comparing Abivertinib Maleate to Gefitinib in advanced non-small cell lung cancer with sensitive EGFR mutation.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for the Symptom Experience Study in persons with non-small cell lung cancer (Phase 1/Phase 2) completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Probiotics Combined With Chemotherapy for Patients With Advanced NSCLC [Phase 3]
Phase 3 trial evaluating probiotics in combination with chemotherapy for advanced non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery [Phase 2]
Phase 2 clinical trial investigating the efficacy of GSK 249553 vaccine in treating non-small cell lung cancer after surgical tumor removal;…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing nivolumab to docetaxel in previously treated advanced or metastatic non-small cell lung cancer completed, with resul…
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC [Phase 2]
Phase 2 clinical trial investigating the use of liquid biopsy to monitor resistance to EGFR TKIs, including osimertinib, in EGFR-mutant non-…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer [NA]
A clinical trial update describes investigating a mitochondria-targeted system therapy combined with radiofrequency ablation for early-stage…
-
CLINICAL_TRIALS safety_alert · 2019-02-19Clinical Trial Update: Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer
This clinical trial update discusses the side effects observed with anti-PD-1/PD-L1 and anti-CTLA-4 therapies in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2019-02-19Clinical Trial Update: Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC [Phase 2]
This entry reports a Phase 2 clinical trial evaluating AC0010 for EGFR T790M–positive metastatic non-small cell lung cancer; current status …
-
CLINICAL_TRIALS research · 2019-02-19Clinical Trial Update: High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating high-dose icotinib in combination with sequential stereotactic radiosurgery (SRS) for patients with EGFR…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI) [Phase 1, Phase 2]
A Phase 1/2 study evaluating ASP2215 in combination with erlotinib in EGFR activating mutation-positive advanced non-small-cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Nitroglycerin in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of nitroglycerin in non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer
This clinical trial update describes the assessment of epidermal growth factor receptor (EGFR) mutations in the blood of patients with advan…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
This document reports that a Phase III trial of Fruquintinib for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update for LDK378 in crizotinib-naïve adults with ALK-activated non-small cell lung cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and carboplatin with necitumumab in stage IV squamous non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations [Phase 3]
Phase 3 trial comparing ASP8273 to erlotinib or gefitinib in first-line EGFR-mutant non-small cell lung cancer was terminated; results were …
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: The Tracking Molecular Evolution for NSCLC (T-MENC) Study
An update on the Tracking Molecular Evolution for non-small cell lung cancer (T-MENC) trial, with the study status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC [EARLY_Phase 1]
A pilot Phase 1 study evaluated atezolizumab (MPDL3280A) in combination with HIGRT for metastatic non-small cell lung cancer. The trial has …
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC [Phase 1]
This Phase 1b trial evaluates PEGPH20 plus docetaxel in recurrent or metastatic non-small cell lung cancer; the study was terminated with re…
-
CLINICAL_TRIALS research · 2019-02-08Clinical Trial Update: PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy [EARLY_Phase 1]
This Clinical Trial Update reports on an early-phase 1 study using PET quantitative assessments to measure solid tumor response to immune ch…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial assessing concurrent proton therapy with chemotherapy in locally advanced stage IIIA/IIIB non-small cell lung cancer; results …
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recru…